Search Results 61-70 of 17310 for egfr

1. A Dose Escalation Study Of Amivantamab In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Cohort C: Subjects with primary EGFR mutated disease, with a documented EGFR ... Previous treatment with an EGFR TKI with activity against EGFR Exon 20 insertions ...

2. Atezolizumab and hyaluronidase-tqjs (subcutaneous route) - Side effects & uses - Mayo Clinic

   ... EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for ...

3. Study Of Efficacy And Safety Of LNP023 In Primary IgA Nephropathy Patients - Mayo Clinic

   * Male and female patients ≥ 18 years of age with an eGFR level and biopsy-confirmed IgA nephropathy as follows: * For patients eGFR\* ≥ 45ml/min/1.73m2 ...

4. Study Of DF9001 In Patients With Advanced Solid Tumors - Mayo Clinic

   The first phase will be a dose escalation phase, enrolling patients with various types of solid tumors that express epidermal growth factor receptor (EGFR).

5. Expert Alert: What a formula change may mean for Black patients in need of a kidney transplant - Mayo Clinic News Network

   Therefore, many health care professionals rely on calculated estimates of the glomerular filtration rate known as eGFR. This estimate is important because ...

6. Hemodialysis - Mayo Clinic

   Your doctor uses your estimated glomerular filtration rate (eGFR) to measure your level of kidney function. Your eGFR is calculated using your blood ...

7. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

   Histologically or cytologically confirmed locally advanced or metastatic EGFRm+ NSCLC harbouring an EGFR mutation known to be associated with EGFR TKI ...

8. A Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients - Mayo Clinic

   ... (eGFR) decline in patients at risk of ... *Eligibility will be confirmed by eGFR value from one of the two first pre-randomization eGFR measurements.

9. Ombitasvir/ABT-450/Ritonavir And Dasabuvir With Or Without Ribavirin In Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease - Mayo Clinic

   ... (eGFR) <30, including those on hemodialysis. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

10. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

    eGFR greater than or equal to 25 mL/ min using CKD EPI formula or a quantified creatinine clearance > 25mL/ min and/or serum creatinine <3.0 mg/dL; Negative ...